Mechanism of hERG channel block by the psychoactive indole alkaloid ibogaine. (Record no. 23337696)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02072 a2200553 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250516183946.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201403s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1521-0103 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1124/jpet.113.209643 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Thurner, Patrick |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20140303 |
245 00 - TITLE STATEMENT | |
Title | Mechanism of hERG channel block by the psychoactive indole alkaloid ibogaine. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | The Journal of pharmacology and experimental therapeutics |
Date of publication, distribution, etc. | Feb 2014 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 346-58 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Amino Acid Substitution |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Binding Sites |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cell Line |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cytosol |
General subdivision | metabolism |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | ERG1 Potassium Channel |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Ether-A-Go-Go Potassium Channels |
General subdivision | antagonists & inhibitors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Excitatory Amino Acid Antagonists |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Hallucinogens |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Hydrogen-Ion Concentration |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Ibogaine |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Ion Channel Gating |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Kinetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Membrane Potentials |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Membrane Transport Modulators |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Molecular Conformation |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Molecular Docking Simulation |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Mutant Proteins |
General subdivision | agonists |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Narcotic Antagonists |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Nerve Tissue Proteins |
General subdivision | antagonists & inhibitors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Recombinant Proteins |
General subdivision | chemistry |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Stary-Weinzinger, Anna |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Gafar, Hend |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Gawali, Vaibhavkumar S |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kudlacek, Oliver |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Zezula, Juergen |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Hilber, Karlheinz |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Boehm, Stefan |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Sandtner, Walter |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Koenig, Xaver |
773 0# - HOST ITEM ENTRY | |
Title | The Journal of pharmacology and experimental therapeutics |
Related parts | vol. 348 |
-- | no. 2 |
-- | p. 346-58 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1124/jpet.113.209643">https://doi.org/10.1124/jpet.113.209643</a> |
Public note | Available from publisher's website |
No items available.